Root Financial Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Root Financial Partners’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$87.9K	Buy	+1,465	New	+$92.3K	﹤0.01%	797
2026 Q2	–	Sell	-2,116	Closed	-$120K	–	780
2026 Q1	$120K	Buy	2,116 +1,726	+443%	+$101K	0.01%	500
2025 Q4	$23.2K	Buy	390 +59	+18%	+$3.21K	﹤0.01%	1103
2025 Q3	$17.9K	Buy	+331	New	+$18.9K	﹤0.01%	1169

Other funds holding BMRN

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

ARGA Investment Management Stamford, Connecticut $3.94B AUM 28.9% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Root Financial Partners's BMRN Position: Q3 2026 in Review

Root Financial Partners opened a new position in BioMarin Pharmaceuticals (BMRN) in Q3 2026: 1,465 shares worth $87.9K. The stake represents ﹤0.01% of the portfolio and ranks #797 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in BMRN as recently as Q1 2026.

Root Financial Partners first reported a position in BMRN in Q3 2025 and has held it in 4 quarters since. The position peaked at $120K in Q1 2026. 249 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

Root Financial Partners held 1,465 shares of BioMarin Pharmaceuticals worth $87.9K as of Q3 2026.
BioMarin Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
BioMarin Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #797 holding.
Root Financial Partners first reported a position in BioMarin Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
Root Financial Partners's BioMarin Pharmaceuticals position peaked at $120K in Q1 2026.
249 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.